Your session is about to expire
← Back to Search
Acthar for Rheumatoid Arthritis
Study Summary
This trial is testing whether Acthar, a medication used to treat flares in RA, can help improve symptoms as measured by MSUS and disease activity scores.
- Rheumatoid Arthritis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: 40 Units
- Group 2: 80 Units
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What medical applications is 40 Units commonly employed for?
"40 units of this medication are typically given to treat acute coryza. Moreover, it has been used effectively in treating rheumatoid arthritis, juvenile optic neuritis, and dermatomyositis."
What is the upper limit of participants in this scientific evaluation?
"Correct. According to the clinicaltrials.gov website, this medical trial is actively enrolling patients since its initial posting on July 20th 2017 and has been recently updated on November 4th 2022. 40 participants are being sought from a single site for this research endeavour."
What other research efforts have included a 40 Unit sample size?
"Currently, there are 9 different medical trials taking place for 40 Units with 2 of them in their late-stage phase. Most of the studies take place Minneapolis, Minnesota however 104 other locations across the world also offer this medication."
Does this research offer opportunities for individuals to participate?
"Correct. Data hosted on clinicaltrials.gov reveals that this medical experiment, which was originally published on July 20th 2017, is presently recruiting participants. Forty individuals need to be enrolled from 1 separate site."
Does the FDA recognize 40 Units as an approved dosage?
"Our team at Power has assigned a score of 3 to the safety of 40 Units, as this medical intervention is supported by Phase 4 trials and hence approved."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger